Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...
At this year's American College of Rheumatology (ACR) annual meeting, researchers highlighted emerging approaches aimed at ...
News-Medical.Net on MSN
Researchers develop nasal antiviral platform using AI technology to block flu and COVID-19
Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block ...
All Penny Stocks (English) on MSN
Phase 1 Results Drive New Attention to Breast Cancer Play
(CSE: BIOV) (OTCQB: BVAXF) are trading higher Wednesday after the company reported positive Phase 1 clinical results for its investigational immunotherapy maveropepimut S, or MVP S, in women with ...
Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
A new study published in the Journal of Alzheimer’s Disease revealed that clinical periodontitis was not linked to the onset ...
Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results